Effect of annatto-tocotrienols supplementation on the Development of Mammary Tumors in HER-2/neu Transgenic Mice

被引：0
|
作者：
Pierpaoli, E. [1 ]
Viola, V. [1 ]
Barucca, A. [1 ]
Orlando, F. [1 ]
Galli, F. [1 ]
Provinciali, M. [1 ]
机构：
[1] Univ Perugia, I-06100 Perugia, Italy
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2012年 / 53卷
关键词：
Desmethylated tocotrienols; Mammary tumors; Cancer therapy; HER-2/neu transgenic mice;
D O I：
10.1016/j.freeradbiomed.2012.08.518
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [21] DNA vaccination with full-length or truncated Neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice
    Amici, A
    Smorlesi, A
    Noce, G
    Santoni, G
    Cappelletti, P
    Capparuccia, L
    Coppari, R
    Lucciarini, R
    Petrelli, C
    Provinciali, M
    GENE THERAPY, 2000, 7 (08) : 703 - 706
  • [22] HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice
    Manjili, MH
    Wang, XY
    Chen, X
    Martin, T
    Repasky, EA
    Henderson, R
    Subjeck, JR
    JOURNAL OF IMMUNOLOGY, 2003, 171 (08): : 4054 - 4061
  • [23] Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice
    Jacob, Jennifer
    Radkevich, Olga
    Forni, Guido
    Zielinski, John
    Shim, David
    Jones, Richard F.
    Wei, Wei-Zen
    CELLULAR IMMUNOLOGY, 2006, 240 (02) : 96 - 106
  • [24] Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
    Mauro Provinciali
    Alessandra Barucca
    Fiorenza Orlando
    Elisa Pierpaoli
    Scientific Reports, 7
  • [25] Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
    Provinciali, Mauro
    Barucca, Alessandra
    Orlando, Fiorenza
    Pierpaoli, Elisa
    SCIENTIFIC REPORTS, 2017, 7
  • [26] Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice
    Takeuchi, N
    Hiraoka, SI
    Zhou, XY
    Nagafuku, M
    Ono, S
    Tsujimura, T
    Nakazawa, M
    Yura, Y
    Hamaoka, T
    Fujiwara, H
    CANCER RESEARCH, 2004, 64 (20) : 7588 - 7595
  • [27] Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination
    Pupa, SM
    Iezzi, M
    Di Carlo, E
    Invernizzi, A
    Cavallo, F
    Meazza, R
    Comes, A
    Ferrini, S
    Musiani, P
    Ménard, S
    CANCER RESEARCH, 2005, 65 (03) : 1071 - 1078
  • [28] Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice
    Nanni, P
    Nicoletti, G
    De Giovanni, C
    Croci, S
    Astolfi, A
    Landuzzi, L
    Di Carlo, E
    Iezzi, M
    Musiani, P
    Lollini, PL
    CANCER RESEARCH, 2003, 63 (11) : 2728 - 2732
  • [29] Electroporated DNA vaccine clears away multifocal mammary carcinomas in Her-2/neu transgenic mice
    Quaglino, E
    Iezzi, M
    Mastini, C
    Amici, A
    Pericle, F
    Di Carlo, E
    Pupa, SM
    De Giovanni, C
    Spadaro, M
    Curcio, C
    Lollini, PL
    Musiani, P
    Forni, G
    Cavallo, F
    CANCER RESEARCH, 2004, 64 (08) : 2858 - 2864
  • [30] Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-γ and B cell dependent
    Nanni, P
    Landuzzi, L
    Nicoletti, G
    De Giovanni, C
    Rossi, I
    Croci, S
    Astolfi, A
    Iezzi, M
    Di Carlo, E
    Musiani, P
    Forni, G
    Lollini, PL
    JOURNAL OF IMMUNOLOGY, 2004, 173 (04): : 2288 - 2296
12345